Careers  |  Sign In  |  Register  |   Twitter

Latest in Arthritis

A recent case study from the Yale School of Medicine has found that tofacitinib, a drug frequently used to treat rheumatoid arthritis, has successfully treated a patient’s vitiligo reports CBS News. The condition is characterized by loss of pigmentation in the skin and after five months of treatment the...
According to Reuters, an experimental drug that infamously caused horrific side effects almost a decade ago, from a ballooned head on one patient, to lost fingertips and toes on another, is back in tests for rheumatoid arthritis. Scientists have since learned to study the interaction of the drug with human...
According to CBS News, a study published in Arthritis & Rheumatology found that recovery workers who participated in efforts at Ground Zero face a greater risk for rheumatoid arthritis and other autoimmune diseases. While previous research has found increased rates of certain cancers and respiratory...